To examine the usefulness of including sodium (Na) levels as a criterion to the SOAR stroke score in predicting inpatient and 7-day mortality in stroke.
Dysnatremia, either hypo-or hypernatraemia, is the commonest electrolyte abnormality in hospitalized patients. 10 Indeed, both hypoand hypernatraemia have been shown to increase inpatient mortality in various settings including intensive care units and emergency departments. [10] [11] [12] Recently, studies have established that hyponatremia increases both short-and long-term mortality in stroke patients.
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We hypothesize that the addition of sodium levels would improve the performance of SOAR stroke score.
This study aimed to examine if the addition of sodium levels (forming the SOAR-Na score) would considerably better the prognostic ability of the SOAR stroke score. Also of interest was to explore the performance of the SOAR-Na score in comparison to the SOAR stroke score in patient populations characterized by conditions that may particularly influence sodium handling and levels -those with or without chronic kidney disease (CKD) and those with or without hyperglycaemia, respectively.
| MATERIALS AND METHODS
The participants were drawn from the Norfolk and Norwich University The variables included in this study were sex, plasma sodium levels on admission (same day or closest to admission), status at discharge (dead or alive), dates of admission and discharge. In addition to this were all variables needed to calculate the SOAR stroke score: age, prestroke mRs, stroke subtype and OCSP classification. The outcomes of interest were inpatient and 7-day mortality. Inpatient mortality refers to patients who die before discharge from hospital, while 7-day mortality refers to death within 7 days regardless of status at discharge. Sodium levels on admission were split into five categories based on standard cut-off points used in clinical practice. These were severe hyponatremia (<125 mmol/L), 
| Statistical analysis
Analysis was performed using SPSS V.23.0 (Chicago, Illonois, US, USA).
Univariate and then multivariate logistic regression models were constructed for both inpatient and 7-day mortality outcomes. The results of the multivariate model that adjusted for SOAR variables were used to assign score values for sodium categories. Then, a separate logistic regression model was constructed to check the value of points assigned to sodium categories. This analysis adjusted for a calculated SOAR stroke score as opposed to actual values of individual variables.
Based on the results of these models, both severe hyponatremia and
hypernatraemia were assigned one point each and added to the SOAR stroke score, forming the SOAR-Na stroke score (Table S1 ).
Due to relatively small numbers of patients who scored very high scores, those with scores 5 and 6 were combined for SOAR and those who were scoring 5, 6 and 7 were combined for the SOAR-Na score.
The diagnostic ability of the SOAR and SOAR-Na score for both inpatient and 7-day mortality was determined by sensitivity, specificity, negative predictive value (NPV) and positive predictive value (PPV) for each increment of the score point. Then the discriminating ability of SOAR and SOAR-Na was compared using Receiver Operating Characteristic (ROC) Curves. An analysis was also run stratifying those whose sodium level was taken at the same day of admission and those whose level was measured afterwards.
Subanalyses were conducted using STATA Version 13.0 (College Station, Texas, USA). This analysis involved stratifying each of the ROC curves by diagnosis of chronic kidney disease or by glucose levels:
Glucose categories were hypoglycaemia (<4.0 mmol/L), normoglycemia (4.0-7.8 mmol/L), borderline hyperglycaemia (7.9-11.0 mmol/L) and hyperglycaemia (>11.0 mmol/L). Some had missing data for glucose levels at admission, thus for glucose analysis the sample consisted of 6550 patients.
| RESULTS
The NNUSTR had a total of 11 886 entries between January 2003 and May 2015. Of them, 3393 records were excluded from this study (see Fig. 1 for exclusions). The included cases had similar characteristics compared with the whole sample (Table S2 ). A total of 8493 patients with acute stroke were included in the study. The sample mean age was 77.7
years (SD±11.6 years), 47.4% were male. Approximately 19.5% of cases died as inpatients and 9.5% died within 7 days of admission. Table 1 shows the sample characteristics. In total, 88.4% of the sample had an ischaemic stroke and the most common OCSP classification was partial anterior circulation stroke (35.7%). In total, 63.7% of the patients had no prestroke disability (prestroke mRs=0) and the majority of cases (84.3%)
had normal sodium levels on admission. The baseline point prevalence of hypernatraemia was 1.8%. The prevalences for mild, moderate and severe hyponatremia were 10.6%, 2.6% and 0.7%, respectively.
Univariate analysis showed that all levels of dysnatremia had increased odds of both inpatient and 7-day mortality. Hypernatraemia appeared to have the largest impact on inpatient mortality, OR 3.04 (95% CI: 2.18-4.24) while severe hyponatremia had the largest impact for 7-day mortality OR 3.00 (1.61-5.60). Multivariate analysis controlling for SOAR stroke score variables showed that those with hypernatraemia were more likely to die as an inpatient in comparison to those with normal sodium levels (OR 2.56 [1.71-3.84]). Furthermore, moderate and severe hyponatremia showed a statistically significant association with 7-day mortality, the latter appearing to have the highest risk: ORs 2.00 (1.33-3.01) and 3.13 (1.56-6.29), respectively ( Table 2) . Analysis utilizing the SOAR stroke score as a single categorical variable revealed similar results (Table S3) .
When predicting inpatient mortality the SOAR stroke and SOAR- (.77-.80). A statistically significant difference between the two scores was observed when predicting inpatient mortality (P value=.04), although the absolute improvement was minimal. Sodium levels were measured on the same day for the majority of the sample (84.7%).
Repeating the analysis stratifying those whose sodium level was taken at the same day of admission and those whose level was measured afterwards showed little difference in the predictive ability of the either the SOAR or SOAR-Na score (data not shown).
The sensitivities, specificities, PPVs and NPVs for each increment of score point for the SOAR stroke and SOAR-Na scores are shown for both mortality outcomes in Table 3 . Both scores performed better in those without CKD compared with those with CKD for both mortality time points. In relation to glucose categories, both scores' predictive ability for inpatient and 7-day mortality is statistically significantly higher in patients with hypoglycaemia. Both scores also performed better in those with normoglycemia when predicting 7-day mortality (although to a lesser degree) ( Table 4 ).
| DISCUSSION
Our findings support previously observed associations between dysnatremia and early mortality in stroke. [13] [14] [15] A U-shaped relationship is present with severe and moderate hyponatremia and hypernatraemia showing statistical significance once other variables relevant to the SOAR stroke score were adjusted for. Increased odds of mortality displayed in those with hyponatremia may be attributed to osmotic changes causing cerebral oedema and increased intracranial pressure leading to a subsequent increase in cell dysfunction and death.
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Excess mortality observed in those with hypernatraemia may be due to neurological impairment, 12 but is more likely to be a marker of dehydration and advanced frailty. 15 Hypernatraemia has also been associated with early neurological worsening. 16 In comparison to preceding literature, the models utilized to predict mortality outcomes had a much smaller degree of adjustment.
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The aim of the models used within this study was to establish if sodium levels perform independently of the variables used within the SOAR stroke score. Considerably fewer variables were therefore controlled for. This is important to note in respect to hypernatraemia's association with mortality. Soiza et al.'s 15 sample is comparable to the one in this study (their sample is taken from the same register but from an earlier time point). Although Soiza et al. 15 also showed this association, this was lost when serum urea, another measure of dehydration, was controlled for along with other haematological and biochemistry variables.
The addition of sodium to the SOAR stroke score does not appear to make a noteworthy impact on the score's predictive ability. While there is a statistically significant difference when predicting inpatient mortality, the minor difference in absolute terms means this is unlikely to be a useful tool over SOAR. Similarly, the SOAR-Na score was not superior to the SOAR stroke score with regard to 7-day mortality prediction. The minor increase in the performance observed may be partly attributed to the fact that higher scores were combined in both indices No., number of deaths; Cum%, cumulative percentage of those who died; PPV, positive predictive value; NPV, negative predictive value.
(due to their small numbers), perhaps reducing the discriminative ability of the SOAR-Na score. An alternative possible explanation is the presence of a mechanistic link between the SOAR stroke score and dysnatremias. Dysnatremias could possibly mediate the poor outcome in patients with characteristics fulfilling a high SOAR stroke score (e.g.
older age, higher prestroke mRs, more severe stroke).
Myint et al. 8 have shown that the SOAR stroke score accurately predicts length of stay, this has been validated by the same group.
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While not examined within this study, the addition of sodium may be more useful in predicting length of stay as opposed to early mortality outcomes. Hyponatremia has not only been independently associated with an increased length of stay within an unselected population 18, 19 but also increased use of hospital resources and cost.
18,19
The SOAR-Na score appears to perform poorly in those with CKD (although still marginally better than the SOAR stroke score). Within this subgroup, renal function is the main determinant of outcome 20 and compromized water homoeostasis means that dysnatremias are more likely. [20] [21] [22] It is worth noting that the sample size was small when we confined analysis to those with history of CKD. Additional research with a larger sample would be required to confirm or refute the current study findings.
Both the SOAR and SOAR-Na score's predictive ability was considerably increased in those with hypoglycaemia for both mortality
outcomes. An unexpected finding was the SOAR stroke score actually performed slightly better. This finding, however, could be influenced by the small number of cases (N=56) within this category. While the overall sample size is reasonable (>6500 cases) individual categories held small numbers of cases possibly contributing to non-significant results. As glucose concentration rises, sodium concentration falls due to water shifts from the intracellular to extracellular compartment.
Examining how this could impact the performance of the SOAR-Na score in a larger sample would be of interest.
In conclusion, this study further supports that sodium is an independent predictor of mortality after stroke. The addition of sodium levels as a criterion to the SOAR stroke score, however, does not make a substantial increase in the score's predictive ability with regard to 7-day and inpatient mortality outcomes. Nonetheless, the performance of the SOAR-Na score may still be of interest in particular groups, namely those with dysglycemia and CKD and other patient related outcomes.
ACKNOWLEDGMENTS
We thank the stroke data team for their contribution to maintain the NNUH stroke & TIA.
FUNDING
The NNUH Stroke and TIA Register is maintained by the NNUH NHS Foundation Trust Stroke Services and data management for this study is supported by the NNUH Research and Development Department through Research Capability Funds.
CONFLICTS OF INTEREST
The authors declare no conflicts of interest.
T A B L E 4
Comparison of predictive ability of SOAR stroke and SOAR-Na scores for 7-day and inpatient mortality in all patients and stratified by presence of chronic kidney disease and by glucose categories 
